Llwytho...
A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products
There have been several new treatment approaches established for the management of hyperglycemia in type 2 diabetes (T2D), with treatment guidelines listing both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and basal insulin therapies as considerations for patients who have failed to contro...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Adv Endocrinol Metab |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813858/ https://ncbi.nlm.nih.gov/pubmed/29492243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018817752315 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|